Relay Therapeutics (RLAY) CFO Thomas Catinazzo Sells Shares

What Happened
Thomas Catinazzo, Chief Financial Officer of Relay Therapeutics (RLAY), sold 17,717 shares in an open-market transaction on August 14, 2026. The weighted-average sale price was $19.74 per share (range $19.51–$19.96), for total proceeds of approximately $349,734. This disposition was reported as a sale (S).

Key Details

• Transaction date: August 14, 2026 (filed with the SEC on August 18, 2026 — timely within two business days).
• Price: weighted average $19.74; execution occurred in multiple trades at $19.51–$19.96.
• Shares sold: 17,717; proceeds ≈ $349,734.
• Shares owned following transaction: not specified in the provided summary; filing notes that reported holdings include 6,538 shares underlying restricted stock units.
• Notable footnotes: transaction was made pursuant to a Rule 10b5-1 trading plan adopted Oct 30, 2025 (pre-arranged trades); the filer can provide a breakdown of shares sold at each price upon request.

Context
Sales executed under 10b5-1 plans are pre-scheduled and often reflect routine disposition rather than a contemporaneous view on the company. For retail investors, purchases are generally more informative about insider sentiment; this filing documents a planned sale executed across multiple trades.